8-K Announcements
6Material company update
Mar 25, 2026·SEC
Material company update
Feb 12, 2026·SEC
Material company update
Nov 17, 2025·SEC
Celcuity Inc.(CELC)Earnings, Financials & Key Ratios
CELC•NASDAQ
$139.44
$6.03B mkt cap·Price updated May 6, 2026
AboutCelcuity Inc., a clinical stage biotechnology company, focuses on the development of molecularly targeted therapies for cancer patients in the United States. The company's CELsignia diagnostic platform uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the related targeted therapy for the treatment. Its drug candidate includes Gedatolisib, which selectively targets various class I isoforms of PI3K and mammalian target of rapamycin and focus on the treatment of patients with hormone receptor positive, HER2-negative, and advanced or metastatic breast cancer. The company is also developing CELsignia MP test, a qualitative laboratory developed test that measures HER2, c-Met, and PI3K signaling activity in breast and ovarian tumor cells. It had a license agreement with Pfizer, Inc. for the development and commercialization rights to Gedatolisib. Celcuity Inc. was founded in 2011 and is headquartered in Minneapolis, Minnesota.Show more
- Revenue$0
- EBITDA-$113M-71.2%
- Net Income-$112M-75.3%
- EPS (Diluted)-2.83-5.2%
- ROE-87.54%-87.7%
- ROIC-50.32%-47.4%
- Debt/Equity0.85+216.2%
- Interest Coverage-11.02+11.4%
CELC Key Insights
Celcuity Inc. (CELC) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Momentum leader: RS Rating 90 (top 10%)
✗Weaknesses
- ✗Weak Piotroski F-Score: 1/9
- ✗Shares diluted 66.6% in last year
- ✗Expensive at 47.6x book value
- ✗Low asset turnover indicates capital-intensive operations
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
CELC Price & Volume
Celcuity Inc. (CELC) stock price & volume — 10-year historical chart
Loading chart...
CELC Growth Metrics
Celcuity Inc. (CELC) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years-
3 Years-
TTM-
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-73.16%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-40.61%
Return on Capital
10 Years-45.13%
5 Years-49.7%
3 Years-42.52%
Last Year-58.02%
CELC Recent Earnings
Celcuity Inc. (CELC) EPS & revenue vs analyst estimates — last 4 quarters
●Beat EPS 8/12 qtrs (67%)
Q2 2026Latest
Mar 25, 2026EPS
$0.97
Est $1.06
+8.5%
Revenue
—
Est $1M
Q4 2025
Nov 12, 2025EPS
$0.92
Est $1.02
+9.8%
Revenue
—
Q3 2025
Aug 14, 2025EPS
$1.04
Est $0.90
-15.6%
Revenue
—
Q2 2025
May 14, 2025EPS
$0.86
Est $0.95
+9.5%
Revenue
—
| Quarter | Date | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|---|
| Q2 2026Latest | Mar 25, 2026 | $0.97vs $1.06+8.5% | —vs $1M |
| Q4 2025 | Nov 12, 2025 | $0.92vs $1.02+9.8% | — |
| Q3 2025 | Aug 14, 2025 | $1.04vs $0.90-15.6% | — |
| Q2 2025 | May 14, 2025 | $0.86vs $0.95+9.5% | — |
Based on last 12 quarters of dataView full earnings history →
CELC Peer Comparison
Celcuity Inc. (CELC) competitors in Oncology Therapeutics Developers — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 RVMD | 32.12B | 151.07 | -25.39 | -83.22% | 0.10 | |||
 KYMR | 7.04B | 86.26 | -23.38 | -16.72% | -6.12% | -25.02% | 0.05 | |
 TNGX | 3.21B | 23.62 | -27.15 | 48.29% | -162.85% | -50.3% | 0.10 | |
 PMVP | 76.84M | 1.45 | -1.27 | -55.34% | 0.01 | |||
 ACLX | 6.73B | 115.07 | -28.27 | -79.35% | -10.27% | -55.42% | 0.24 | |
 NUVL | 6.92B | 104.26 | -26.53 | -45.12% | ||||
 AGEN | 137.4M | 3.89 | -1144.12 | 10.37% | 0.1% | |||
 MGNX | 190.59M | 3.01 | -2.55 | 0.78% | -49.91% | -120.2% | 0.66 |
Compare CELC vs Peers
Celcuity Inc. (CELC) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
CELC Income Statement
Celcuity Inc. (CELC) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 73.06K | 104.7K | 223.04K | 0 | 0 | 0 | 0 | 0 | 0 | 76.25K |
| COGS % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Gross Profit | -73.06K▲ 0% | -104.7K▼ 43.3% | -223.04K▼ 113.0% | 0▲ 100.0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | 0▲ 0% | -76.25K▲ 0% |
| Gross Margin % | - | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | -25.15% | -43.31% | -113.02% | 100% | - | - | - | - | - | - |
| Operating Expenses | 3.33M | 5.95M | 7.93M | 7.81M | 9.56M | 28.36M | 39.39M | 66.23M | 113.27M | 159.39M |
| OpEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 263.66K | 972.52K | 1.61M | 1.78M | 2.13M | 2.6M | 4.38M | 5.64M | 9.06M | 18.55M |
| SG&A % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Research & Development | 3.06M | 4.98M | 6.33M | 6.27M | 7.68M | 25.76M | 35.29M | 60.59M | 104.2M | 140.84M |
| R&D % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | 0 | 0 | 0 | -247.14K | -256.8K | 0 | -278.84K | 0 | 0 | 0 |
| Operating Income | -3.33M▲ 0% | -5.95M▼ 78.9% | -7.93M▼ 33.3% | -7.81M▲ 1.6% | -9.56M▼ 22.4% | -28.36M▼ 196.7% | -39.39M▼ 38.9% | -66.23M▼ 68.1% | -113.27M▼ 71.0% | -159.42M▲ 0% |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -47.16% | -78.85% | -33.25% | 1.6% | -22.43% | -196.73% | -38.92% | -68.14% | -71.02% | - |
| EBITDA | -3.26M | -5.85M | -7.71M | -7.47M | -9.17M | -28.05M | -39.18M | -66.09M | -113.14M | -159.27M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -47.74% | -79.65% | -31.83% | 3.15% | -22.83% | -205.9% | -39.67% | -68.68% | -71.19% | -65.14% |
| D&A (Non-Cash Add-back) | 73.06K | 104.7K | 223.04K | 339K | 385.59K | 303.24K | 210.92K | 142.77K | 129.95K | 153.25K |
| EBIT | -3.33M | -5.95M | -7.48M | -7.81M | -9.56M | -28.34M | -39.39M | -58.45M | -101.5M | -135.69M |
| Net Interest Income | 0 | -298.79K | 448.72K | 445.94K | 81.99K | -1.25M | -978.95K | 2.45M | 1.49M | -16.07M |
| Interest Income | 18.02K | 152.88K | 448.83K | 446.1K | 82.11K | 13.26K | 1.13M | 7.78M | 11.77M | 10.96M |
| Interest Expense | 0 | 451.66K | 111 | 159 | 120 | 1.26M | 2.11M | 5.33M | 10.28M | 27.03M |
| Other Income/Expense | 18.02K | -298.79K | 451.72K | 445.94K | 81.99K | -1.25M | -978.95K | 2.45M | 1.49M | -3.3M |
| Pretax Income | -3.31M▲ 0% | -6.25M▼ 88.9% | -7.48M▼ 19.7% | -7.36M▲ 1.6% | -9.47M▼ 28.7% | -29.61M▼ 212.5% | -40.37M▼ 36.4% | -63.78M▼ 58.0% | -111.78M▼ 75.3% | -162.72M▲ 0% |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 0 | 48.17K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | -0.77% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Net Income | -3.31M▲ 0% | -6.25M▼ 88.9% | -7.48M▼ 19.7% | -7.36M▲ 1.6% | -9.47M▼ 28.7% | -29.61M▼ 212.5% | -40.37M▼ 36.4% | -63.78M▼ 58.0% | -111.78M▼ 75.3% | -162.72M▲ 0% |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | -46.38% | -88.85% | -19.66% | 1.62% | -28.74% | -212.48% | -36.36% | -57.99% | -75.26% | -73.16% |
| Net Income (Continuing) | -3.31M | -6.25M | -7.48M | -7.36M | -9.47M | -29.61M | -40.37M | -63.78M | -111.78M | -162.72M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -0.49▲ 0% | -0.84▼ 71.4% | -0.74▲ 11.9% | -0.69▲ 6.8% | -0.89▼ 29.0% | -2.28▼ 156.2% | -2.68▼ 17.5% | -2.69▼ 0.4% | -2.83▼ 5.2% | -3.63▲ 0% |
| EPS Growth % | -36.11% | -71.43% | 11.9% | 6.76% | -28.99% | -156.18% | -17.54% | -0.37% | -5.2% | -40.61% |
| EPS (Basic) | -0.49 | -0.84 | -0.74 | -0.69 | -0.89 | -2.28 | -2.68 | -2.69 | -2.83 | - |
| Diluted Shares Outstanding | 6.72M | 7.46M | 10.12M | 10.23M | 10.27M | 13.38M | 15.42M | 23.68M | 39.45M | 44.79M |
| Basic Shares Outstanding | 6.72M | 7.46M | 10.12M | 10.23M | 10.27M | 13.38M | 15.42M | 23.68M | 39.45M | 44.79M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
CELC Balance Sheet
Celcuity Inc. (CELC) balance sheet — assets, liabilities & shareholders' equity
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 5.91M | 24.48M | 25.22M | 19.25M | 12.17M | 85.35M | 175.16M | 190.59M | 244.57M | 475.5M |
| Cash & Short-Term Investments | 5.86M | 24.2M | 24.9M | 18.76M | 11.66M | 84.29M | 168.59M | 180.58M | 235.1M | 454.98M |
| Cash Only | 5.86M | 2.64M | 15.94M | 18.74M | 11.64M | 84.29M | 24.57M | 30.66M | 22.51M | 74.25M |
| Short-Term Investments | 0 | 21.56M | 8.95M | 22.01K | 22.01K | 0 | 144.02M | 149.92M | 212.59M | 380.73M |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 298.76K | 203.66K | 805.88K | 1.6M | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 50K | 50K | 28.74K | 218.74K | 190K | 22.14K | 22.01K | 281.36K | 841.33K | 20.52M |
| Total Non-Current Assets | 144.91K | 7.49M | 813.61K | 1.03M | 789.79K | 554.35K | 539.75K | 628.8K | 552.02K | 507K |
| Property, Plant & Equipment | 144.91K | 280.06K | 813.61K | 1.03M | 789.79K | 554.35K | 506.56K | 628.8K | 552.02K | 507K |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 7.21M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 33.2K | 0 | 0 | 0 |
| Total Assets | 6.06M▲ 0% | 31.97M▲ 427.8% | 26.03M▼ 18.6% | 20.28M▼ 22.1% | 12.96M▼ 36.1% | 85.91M▲ 563.0% | 175.7M▲ 104.5% | 191.22M▲ 8.8% | 245.12M▲ 28.2% | 476M▲ 0% |
| Asset Turnover | - | - | - | - | - | - | - | - | - | 0.00x |
| Asset Growth % | 14.28% | 427.81% | -18.57% | -22.09% | -36.11% | 563.02% | 104.52% | 8.83% | 28.19% | 81.2% |
| Total Current Liabilities | 445.36K | 578.05K | 662.33K | 911.33K | 1.19M | 2.51M | 6.88M | 14.19M | 31.72M | 38.79M |
| Accounts Payable | 331.53K | 71.91K | 119.81K | 142.77K | 217.38K | 1.51M | 2.63M | 5.08M | 9.37M | 11.42M |
| Days Payables Outstanding | 1.66K | 250.69 | 196.07 | - | - | - | - | - | - | 50.11K |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 194.2K | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 0 | 54.51K | 63.88K | 0 | 0 | 472.93K | 3.09M | 7.11M | 0 | 0 |
| Current Ratio | 13.27x | 42.36x | 38.07x | 21.12x | 10.26x | 34.06x | 25.45x | 13.43x | 7.71x | 7.71x |
| Quick Ratio | 13.27x | 42.36x | 38.07x | 21.12x | 10.26x | 34.06x | 25.45x | 13.43x | 7.71x | 7.71x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 19.88K | 71.9K | 69.16K | 14.69M | 35.04M | 37.26M | 97.78M | 320.25M |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 14.63M | 34.98M | 37.04M | 97.73M | 320.25M |
| Capital Lease Obligations | 0 | 0 | 19.88K | 71.9K | 69.16K | 64.22K | 61K | 225.92K | 53.97K | 66.97K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 445.36K | 578.05K | 682.21K | 983.23K | 1.25M | 17.2M | 41.93M | 51.45M | 129.5M | 359.04M |
| Total Debt | 0 | 0 | 25.61K | 256.14K | 262.49K | 14.89M | 35.24M | 37.45M | 97.95M | 320.35M |
| Net Debt | -5.86M | -2.64M | -15.92M | -18.48M | -11.38M | -69.4M | 10.67M | 6.78M | 75.44M | 246.09M |
| Debt / Equity | - | - | 0.00x | 0.01x | 0.02x | 0.22x | 0.26x | 0.27x | 0.85x | 0.85x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | -2.01x |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | -1.55x |
| Interest Coverage | - | -13.18x | -71464.31x | -49089.94x | -79634.70x | -22.46x | -18.70x | -12.43x | -11.02x | -5.02x |
| Total Equity | 5.61M▲ 0% | 31.39M▲ 459.4% | 25.35M▼ 19.2% | 19.3M▼ 23.9% | 11.7M▼ 39.4% | 68.71M▲ 487.2% | 133.77M▲ 94.7% | 139.77M▲ 4.5% | 115.62M▼ 17.3% | 116.96M▲ 0% |
| Equity Growth % | 11.87% | 459.4% | -19.25% | -23.87% | -39.36% | 487.16% | 94.69% | 4.48% | -17.28% | -149.23% |
| Book Value per Share | 0.84 | 4.21 | 2.50 | 1.89 | 1.14 | 5.13 | 8.68 | 5.90 | 2.93 | 2.61 |
| Total Shareholders' Equity | 5.61M | 31.39M | 25.35M | 19.3M | 11.7M | 68.71M | 133.77M | 139.77M | 115.62M | 116.96M |
| Common Stock | 6.44K | 10.09K | 10.19K | 10.25K | 10.3K | 14.92K | 21.67K | 25.51K | 37.14K | 116.96M |
| Retained Earnings | -8.33M | -2.01M | -9.49M | -16.85M | -26.32M | -55.93M | -96.3M | -160.08M | -271.86M | 0 |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -155.41K | -260.12K | -480.9K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CELC Cash Flow Statement
Celcuity Inc. (CELC) cash flow — operating, investing & free cash flow history
| Line item | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | Dec'24 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -2.89M | -4.95M | -6.08M | -6M | -7.15M | -20.31M | -36.01M | -53.81M | -83.47M | -83.47M |
| Operating CF Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating CF Growth % | -45.96% | -71.31% | -22.8% | 1.28% | -19.12% | -184.25% | -77.28% | -49.44% | -55.11% | -378.27% |
| Net Income | -3.31M | -6.25M | -7.48M | -7.36M | -9.47M | -29.61M | -40.37M | -63.78M | -111.78M | -162.72M |
| Depreciation & Amortization | 73.06K | 104.7K | 223.04K | 339K | 385.59K | 303.24K | 210.92K | 142.77K | 129.95K | 153.25K |
| Stock-Based Compensation | 187.31K | 874.39K | 1.17M | 1.04M | 1.76M | 2.61M | 4.64M | 4.9M | 6.99M | 14.24M |
| Deferred Taxes | -187.31K | 0 | -92.32K | 0 | -2.48M | 0 | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 187.31K | 426.57K | 89.32K | 42.91K | 2.48M | 5.56M | 704.66K | 1.06M | 2.84M | 3.86M |
| Working Capital Changes | 161.75K | -101.91K | 15.89K | -62.24K | 179.02K | 819.81K | -1.19M | 3.86M | 18.35M | -183.78K |
| Change in Receivables | 0 | 0 | 0 | -190K | 0 | -108.76K | 95.1K | 0 | 0 | 0 |
| Change in Inventory | 0 | 0 | 0 | 190K | 0 | 0 | 0 | 0 | 0 | 0 |
| Change in Payables | 69.78K | -262.51K | 25.43K | 45.62K | 52.97K | 1.31M | 1.08M | 2.43M | 4.32M | 2.01M |
| Cash from Investing | -40.9K | -28.98M | 19.09M | 8.53M | -89.37K | -81.4K | -144.03M | -5.01M | -63.07M | -129.93M |
| Capital Expenditures | -40.9K | -239.85K | -629.61K | -380.2K | -89.37K | -81.9K | -158.77K | -97.64K | -249.88K | -241.15K |
| CapEx % of Revenue | - | - | - | - | - | - | - | - | - | - |
| Acquisitions | 0 | 0 | 4K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | -28.74M | 4K | 8.91K | 0 | 500 | 0 | 0 | 0 | 0 |
| Cash from Financing | 3.72M | 30.71M | 236.7K | 259.31K | 137.97K | 93.04M | 120.33M | 64.91M | 138.39M | 336.23M |
| Debt Issued (Net) | 0 | 7.49M | -3.32K | -5.73K | -5.77K | 14.34M | 19.5M | -2.45K | 59.23M | 215.87M |
| Equity Issued (Net) | 1000K | 1000K | 0 | 0 | 182.69K | 1000K | 1000K | 1000K | 1000K | 3.27M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | -55.14K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | -894.57K | 240.02K | 265.04K | -38.96K | 148.02K | 324.12K | 50.48M | 15.55M | 15.31M |
| Net Change in Cash | 789.11K▲ 0% | -3.22M▼ 507.6% | 13.25M▲ 512.1% | 2.79M▼ 78.9% | -7.1M▼ 354.3% | 72.65M▲ 1123.6% | -59.71M▼ 182.2% | 6.09M▲ 110.2% | -8.15M▼ 233.8% | 61.65M▲ 0% |
| Free Cash Flow | -2.93M▲ 0% | -5.19M▼ 77.1% | -6.71M▼ 29.3% | -6.38M▲ 4.9% | -7.24M▼ 13.4% | -20.39M▼ 181.9% | -36.17M▼ 77.3% | -53.91M▼ 49.1% | -83.72M▼ 55.3% | -144.89M▲ 0% |
| FCF Margin % | - | - | - | - | - | - | - | - | - | - |
| FCF Growth % | -42.35% | -77.11% | -29.26% | 4.88% | -13.42% | -181.88% | -77.34% | -49.06% | -55.29% | -94.56% |
| FCF per Share | -0.44 | -0.70 | -0.66 | -0.62 | -0.70 | -1.52 | -2.35 | -2.28 | -2.12 | -2.12 |
| FCF Conversion (FCF/Net Income) | 0.87x | 0.79x | 0.81x | 0.82x | 0.75x | 0.69x | 0.89x | 0.84x | 0.75x | 0.89x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 694.53K | 1.26M | 0 | 0 | 4.89M |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
CELC Key Ratios
Celcuity Inc. (CELC) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -62.3% | -33.79% | -26.37% | -32.97% | -61.12% | -73.63% | -39.88% | -46.63% | -87.54% | -179% |
| Return on Invested Capital (ROIC) | - | -31.32% | -31.16% | -114.23% | -1251.29% | - | -41.1% | -34.14% | -50.32% | -50.32% |
| Debt / Equity | - | - | 0.00x | 0.01x | 0.02x | 0.22x | 0.26x | 0.27x | 0.85x | 0.85x |
| Interest Coverage | - | -13.18x | -71464.31x | -49089.94x | -79634.70x | -22.46x | -18.70x | -12.43x | -11.02x | -5.02x |
| FCF Conversion | 0.87x | 0.79x | 0.81x | 0.82x | 0.75x | 0.69x | 0.89x | 0.84x | 0.75x | 0.89x |
CELC SEC Filings & Documents
Celcuity Inc. (CELC) SEC filings — annual & quarterly reports (10-K, 10-Q)
CELC Frequently Asked Questions
Celcuity Inc. (CELC) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Celcuity Inc. (CELC) grew revenue by 0.0% over the past year. Growth has been modest.
Celcuity Inc. (CELC) reported a net loss of $162.7M for fiscal year 2024.
Dividend & Returns
Celcuity Inc. (CELC) has a return on equity (ROE) of -87.5%. Negative ROE indicates the company is unprofitable.
Celcuity Inc. (CELC) had negative free cash flow of $144.9M in fiscal year 2024, likely due to heavy capital investments.
Explore More CELC
Celcuity Inc. (CELC) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates